DTIL Precision BioSciences, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026
$6.31
· of 52w range
· above low
· to high
$3.5852w low
$9.6252w high
Market Cap (MRQ)
$167M
P/E (TTM)
-5.1
EPS (TTM)
$-1.23
Revenue (TTM)
$45M
your badges
52W Range
$4–$10
Analyst Rating
STRONG BUY
Price Target
$29
P/E
-5.1
ROE
-132.9%
Net Profit Margin
-117.0%
Your badge strip is empty — pin a metric anywhere on this page.
DTIL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$6.31
Market Cap (MRQ)
$167M
P/E (TTM)
-5.1
EPS (TTM)
$-1.23
Revenue (TTM)
$45M
ROE (TTM)
-132.9%
52W Range
$4–$10
DTIL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Feb. 14, 2024 | 1-for-30 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$34M2019-12-31 → 2025-12-31
EPS$-3.562021-12-31 → 2025-12-31
Free Cash Flow$-66M2019-12-31 → 2025-12-31
Net margin-117.0%2019-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | DTIL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -5.15Y avg ≈-85.2 | ≈-85.2 | · | · | |
| P/S (TTM) | 3.75Y avg ≈55.8 | ≈55.8 | 6.3 | Undervalued | |
| P/B (MRQ) | 3.75Y avg ≈43.6 | ≈43.6 | 3.4 | Overvalued | |
| Price / FCF (TTM) | -3.25Y avg ≈-186.7 | ≈-186.7 | · | · | |
| Price / Cash Flow (TTM) | -3.25Y avg ≈-267.0 | ≈-267.0 | · | · | |
| Price / Tangible Book (MRQ) | 3.85Y avg ≈44.4 | ≈44.4 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | DTIL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -80.8%5Y avg ≈-142.8% | ≈-142.8% | -529.9% | Top tier | |
| EBITDA Margin | -152.2%5Y avg ≈-142.8% | ≈-142.8% | -226.0% | Top tier | |
| Pretax Margin | -133.4% | · | -772.6% | Top tier | |
| Net Profit Margin (TTM) | -117.0%5Y avg ≈-144.0% | ≈-144.0% | -773.2% | Top tier | |
| ROA (TTM) | -44.9%5Y avg ≈-24.8% | ≈-24.8% | -34.3% | In line | |
| ROE (TTM) | -132.9%5Y avg ≈-100.5% | ≈-100.5% | -39.3% | Weak | |
| ROIC | -56.5% | · | -56.5% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | DTIL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 12.85Y avg ≈6.0 | ≈6.0 | 8.0 | Strong liquidity | |
| Quick Ratio (MRQ) | 12.35Y avg ≈5.7 | ≈5.7 | 7.5 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | DTIL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -50.1%5Y avg ≈76.5% | ≈76.5% | · | · | |
| Revenue CAGR 3Y | 10.9%5Y avg ≈7.0% | ≈7.0% | · | · | |
| Revenue CAGR 5Y | 7.1% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | DTIL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.25Y avg ≈0.3 | ≈0.3 | 0.0 | Top tier | |
| Receivables Turnover | 299.25Y avg ≈108.9 | ≈108.9 | 19.7 | Top tier | |
| Revenue / Employee | ≈$511.4K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
21.6%
Next Report
Nov 02, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 5, 2026 | $-1.26 | $-0.81 | -56.4% |
| March 31, 2026 | May 13, 2026 | $-0.75 | $-0.67 | -12.3% |
| Dec. 31, 2025 | $1.05 | $-0.55 | 292.4% | |
| Sept. 30, 2025 | $-1.84 | $-1.37 | -34.6% | |
| June 30, 2025 | $-2.13 | $-1.60 | -33.3% | |
| March 31, 2025 | $-2.21 | $-1.75 | -26.2% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $34M | $69M | $49M | $25M | $116M | $24M | $22M | |
| R&D Expense | $54M | $60M | $53M | $46M | $115M | $98M | $82M | |
| SG&A Expense | $32M | $35M | $39M | $41M | $40M | $36M | $27M | |
| Operating Expenses | $86M | $95M | $92M | $87M | $155M | $134M | $109M | |
| Operating Income | $-52M | $-26M | $-44M | $-62M | $-39M | $-110M | $-87M | |
| Interest Expense | · | $2M | $2M | $1M | $132.0K | · | $182.0K | |
| Interest Income | · | · | · | · | $208.0K | $822.0K | $4M | |
| Other Non-op | $6M | $33M | $1M | $-11M | $9M | $822.0K | $-6M | |
| Pretax Income | $-46M | $7M | · | · | · | · | · | |
| Income Tax | $0 | $0 | · | · | · | $23.0K | · | |
| Net Income | $-46M | $7M | $-61M | $-112M | $-31M | $-109M | $-93M | |
| EPS (Basic) | $-3.56 | $1.05 | $-15.96 | $-38.10 | $-0.52 | · | · | |
| EPS (Diluted) | $-3.56 | $1.04 | $-15.96 | $-38.10 | $-0.52 | · | · | |
| Shares (Basic) | 12,826,078 | 6,832,982 | 3,841,405 | 2,929,873 | 58,688,102 | · | · | |
| Shares (Diluted) | 12,826,078 | 6,883,911 | 3,841,405 | 2,929,873 | 58,688,102 | · | · | |
| EBITDA | $-52M | $-26M | $-44M | $-100M | $-39M | $-110M | $-87M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $86M | $117M | $190M | $144M | $90M | $181M | |
| Short-term Investments | $5M | $413.0K | · | · | · | · | · | |
| Receivables | $0 | $229.0K | $901.0K | $720.0K | $488.0K | $10M | $965.0K | |
| Prepaid Expense | $3M | $6M | $6M | $6M | $17M | $6M | $9M | |
| Other Current Assets | $45.0K | $369.0K | $419.0K | $1M | $169.0K | $4.0K | $2M | |
| Current Assets | $119M | $95M | $136M | $199M | $162M | $106M | $194M | |
| PP&E (Net) | $1M | $3M | $6M | $12M | $25M | $35M | $40M | |
| PP&E (Gross) | $30M | $31M | $32M | $34M | $49M | $54M | $50M | |
| Accum. Depreciation | $29M | $28M | $25M | $22M | $24M | $19M | $11M | |
| Intangibles | $1M | $622.0K | $400.0K | $731.0K | $2M | $1M | $1M | |
| Other Non-current Assets | $206.0K | $221.0K | $225.0K | $226.0K | $5M | $2M | $558.0K | |
| Total Assets | $154M | $136M | $160M | $238M | $211M | $150M | $235M | |
| Accounts Payable | $296.0K | $1M | $3M | $653.0K | $1M | $792.0K | $2M | |
| Current Liabilities | $9M | $15M | $50M | $60M | $36M | $43M | $27M | |
| Capital Leases | $5M | $6M | $8M | $1M | $5M | $9M | · | |
| Deferred Tax | $1M | $2M | $3M | $1M | $2M | $2M | $1M | |
| Other Non-current Liabilities | $259.0K | $194.0K | $128.0K | $201.0K | $44.0K | $392.0K | · | |
| Total Liabilities | $62M | $80M | $141M | $178M | $120M | $106M | $97M | |
| Long-term Debt | · | · | · | $22M | $2M | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | · | · | · | |
| Retained Earnings | $-528M | $-482M | $-490M | $-428M | $-317M | $-286M | $-177M | |
| Treasury Stock | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | |
| Stockholders' Equity | $92M | $56M | $19M | $60M | $91M | $44M | $138M | |
| Liabilities + Equity | $154M | $136M | $160M | $238M | $211M | $150M | $235M | |
| Shares Outstanding | 24,088,425 | 8,229,730 | 4,191,053 | 3,698,674 | 60,902,105 | 52,692,652 | 51,155,236 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $3M | $7M | $8M | $9M | $9M | $5M | |
| Stock-based Comp | $10M | $13M | $14M | $19M | $17M | $14M | $9M | |
| Amort. of Intangibles | $100.0K | $100.0K | $100.0K | $100.0K | · | · | $100.0K | |
| Operating Cash Flow | $-66M | $-58M | $-84M | $-46M | $-11M | $-87M | $-71M | |
| CapEx | $85.0K | $250.0K | $2M | $3M | $5M | $5M | $25M | |
| Investing Cash Flow | $-634.0K | $-215.0K | $6M | $-3M | $-6M | $-5M | $-25M | |
| Net Debt Issued | · | · | · | · | $-2M | · | · | |
| Stock Issued | · | · | $5M | $49M | $25M | · | · | |
| Net Stock Activity | · | · | $5M | $49M | $25M | · | · | |
| Financing Cash Flow | $95M | $50M | $5M | $95M | $71M | $1M | $173M | |
| Net Change in Cash | $29M | $-8M | $-73M | $46M | $54M | $-91M | $78M | |
| Taxes Paid | $0 | · | · | · | · | · | · | |
| Free Cash Flow | $-66M | $-59M | $-86M | $-49M | $-16M | $-92M | $-96M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -152.2% | -38.1% | -89.8% | -399.9% | -34.1% | -452.2% | -8.2% | |
| Net Margin | -133.4% | 10.4% | -125.8% | -444.8% | -26.5% | -448.9% | -8.7% | |
| Pretax Margin | -133.4% | · | · | · | · | · | · | |
| EBITDA Margin | -152.2% | -38.1% | -89.8% | -399.9% | -34.1% | -452.2% | -8.2% | |
| ROA | -31.4% | 4.8% | -30.8% | -49.6% | -16.9% | -56.6% | -49.7% | |
| ROE | -72.4% | 11.8% | -255.9% | -154.2% | -31.8% | -201.4% | -63.2% | |
| ROIC | -56.5% | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.3 | 6.3 | 2.7 | 3.3 | 4.5 | 2.5 | 7.2 | |
| Quick Ratio | 13.0 | 5.8 | 2.4 | 3.2 | 4.0 | 2.3 | 6.8 | |
| Interest Coverage | · | -14.7 | -19.6 | -90.3 | -298.5 | · | -479.1 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.5 | 0.2 | 0.1 | 0.6 | 0.1 | 5.7 | |
| Receivables Turnover | 299.2 | 121.6 | 60.1 | 41.6 | 22.0 | 4.4 | 1438.2 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.83 | $6.87 | $4.53 | $0.54 | $1.50 | $0.84 | $2.70 | |
| Revenue / Share | $2.67 | $9.98 | $12.68 | $0.29 | · | · | · | |
| Cash Flow / Share | $-5.13 | $-8.49 | $-21.90 | $-0.52 | · | · | · | |
| Cash / Share | $4.60 | $10.47 | $28.02 | $1.71 | $2.36 | $1.70 | $3.54 | |
| EPS (TTM) | $-3.56 | $1.04 | $-15.96 | $-38.10 | $-0.52 | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -50.1% | 41.0% | 94.2% | -78.3% | 375.7% | · | · | |
| Revenue CAGR 3Y | 10.9% | -15.9% | 26.1% | · | · | · | · | |
| Revenue CAGR 5Y | 7.1% | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $34M | $69M | $49M | $25M | $116M | $24M | $22M | |
| Net Income TTM | $-46M | $7M | $-61M | $-112M | $-31M | $-109M | $-93M | |
| Market Cap | $100M | $31M | $46M | $3.96B | $13.52B | $13.18B | $21.32B | |
| P/E | -1.2 | 3.7 | -0.7 | -0.9 | -426.9 | · | · | |
| P/S | 2.9 | 0.5 | 0.9 | 157.8 | 117.0 | 542.9 | 958.6 | |
| P/B | 1.1 | 0.6 | 2.4 | 65.6 | 148.3 | 296.8 | 154.1 | |
| P / Tangible Book | 1.1 | 0.6 | 2.5 | 66.4 | 151.7 | 306.2 | · | |
| P / Cash Flow | -1.5 | -0.5 | -0.5 | -86.6 | -1245.8 | -150.9 | -300.2 | |
| P / FCF | -1.5 | -0.5 | -0.5 | -80.7 | -850.0 | -142.7 | -222.8 | |
| Earnings Yield | -85.6% | 27.3% | -145.8% | -106.7% | -0.23% | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $11M | $34M | $13.0K | $18.0K | $29.0K | $638.0K | $576.0K | $50M | $18M | $7M | $13M | $20M | $9M | $11M | $7M | |
| R&D Expense | $12M | $13M | $14M | $13M | $13M | $14M | $16M | $13M | $17M | $13M | $13M | $16M | $13M | $11M | $-9M | $12M | |
| SG&A Expense | $7M | $7M | $7M | $7M | $9M | $9M | $10M | $9M | $9M | $8M | $9M | $10M | $10M | $11M | $10M | $10M | |
| Operating Expenses | $19M | $20M | $22M | $21M | $22M | $22M | $25M | $22M | $26M | $22M | $22M | $25M | $23M | $22M | $1M | $22M | |
| Operating Income | $-19M | $-9M | $13M | $-21M | $-22M | $-22M | $-25M | $-21M | $24M | $-4M | $-15M | $-12M | $-3M | $-13M | $9M | $-15M | |
| Interest Expense | · | · | · | · | · | $354.0K | · | $256.0K | $560.0K | $574.0K | $579.0K | $576.0K | $553.0K | $522.0K | $486.0K | $405.0K | |
| Other Non-op | $-13M | $-9M | $7M | $-1M | $-2M | $2M | $7M | $5M | $9M | $13M | $1M | $253.0K | $96.0K | $-596.0K | $-7M | $-1M | |
| Net Income | $-33M | $-18M | $20M | $-22M | $-24M | $-21M | $-18M | $-16M | $33M | $9M | $-16M | $-8M | $-12M | $-25M | $-28M | $-24M | |
| EPS (Basic) | $-1.26 | $-0.75 | $2.62 | $-1.84 | $-2.13 | $-2.21 | $-3.10 | $-2.25 | $4.70 | $1.70 | $-3.98 | $-2.10 | $-3.13 | $-6.75 | $-36.96 | $-0.22 | |
| EPS (Diluted) | $-1.26 | $-0.75 | $2.62 | $-1.84 | $-2.13 | $-2.21 | $-3.08 | $-2.25 | $4.67 | $1.70 | $-3.98 | $-2.10 | $-3.13 | $-6.75 | $-36.96 | $-0.22 | |
| Shares (Basic) | 25,856,628 | 24,634,443 | · | 11,818,145 | 11,046,401 | 9,292,066 | · | 7,287,173 | 6,966,680 | 5,060,978 | · | 3,838,900 | 3,803,083 | 3,709,894 | · | 110,849,196 | |
| Shares (Diluted) | 25,856,628 | 24,634,443 | · | 11,818,145 | 11,046,401 | 9,292,066 | · | 7,287,173 | 7,011,630 | 5,063,406 | · | 3,838,900 | 3,803,083 | 3,709,894 | · | 110,849,196 | |
| EBITDA | $-19M | $-9M | · | $-21M | $-22M | $-22M | · | $-21M | $24M | $-4M | · | $-12M | $-12M | $-24M | · | $-23M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $86M | $99M | $111M | $45M | $62M | $77M | $86M | $99M | $124M | $138M | $117M | $122M | $138M | $158M | $190M | $212M | |
| Short-term Investments | $1M | $2M | $5M | $0 | $0 | · | $413.0K | $2M | · | · | · | · | · | · | · | · | |
| Receivables | $0 | $4M | $0 | $4.0K | $0 | $4.0K | $229.0K | $188.0K | $207.0K | $390.0K | $901.0K | $4M | $652.0K | $694.0K | $720.0K | $715.0K | |
| Prepaid Expense | $4M | $4M | $3M | $6M | $7M | $5M | $6M | $7M | $6M | $9M | $6M | $8M | $9M | $8M | $6M | $12M | |
| Other Current Assets | $5.0K | $6.0K | $45.0K | $848.0K | $427.0K | $116.0K | $369.0K | $471.0K | $790.0K | $128.0K | $419.0K | $349.0K | $503.0K | $2M | $1M | $307.0K | |
| Current Assets | $92M | $109M | $119M | $52M | $70M | $82M | $95M | $111M | $144M | $161M | $136M | $146M | $148M | $169M | $199M | $225M | |
| PP&E (Net) | $964.0K | $1M | $1M | $2M | $2M | $3M | $3M | $4M | $4M | $5M | $6M | $9M | $18M | $19M | $12M | $22M | |
| PP&E (Gross) | · | · | $30M | · | · | · | $31M | · | · | · | $32M | · | · | · | $34M | · | |
| Accum. Depreciation | · | · | $29M | · | · | · | $28M | · | · | · | $25M | · | · | · | $22M | · | |
| Intangibles | $1M | $1M | $1M | $985.0K | $605.0K | $607.0K | $622.0K | $388.0K | $375.0K | $386.0K | $400.0K | $977.0K | $2M | $2M | $731.0K | $2M | |
| Other Non-current Assets | $126.0K | $203.0K | $206.0K | $200.0K | $208.0K | $215.0K | $221.0K | $224.0K | $234.0K | $238.0K | $225.0K | $234.0K | $619.0K | $3M | $226.0K | $10M | |
| Total Assets | $126M | $144M | $154M | $94M | $109M | $124M | $136M | $153M | $166M | $185M | $160M | $164M | $182M | $205M | $238M | $272M | |
| Accounts Payable | $828.0K | $944.0K | $296.0K | $1M | $1M | $924.0K | $1M | $958.0K | $1M | $1M | $3M | $531.0K | $781.0K | $701.0K | $653.0K | $1M | |
| Current Liabilities | $7M | $8M | $9M | $15M | $14M | $12M | $15M | $12M | $33M | $33M | $50M | $51M | $56M | $47M | $60M | $61M | |
| Capital Leases | $4M | $4M | $5M | $5M | $6M | $6M | $6M | $7M | $7M | $7M | $8M | · | $3M | $2M | $1M | $3M | |
| Deferred Tax | · | · | $1M | · | · | · | $2M | · | · | · | $3M | · | · | · | $1M | · | |
| Other Non-current Liabilities | $301.0K | $324.0K | $259.0K | $227.0K | $200.0K | $197.0K | $194.0K | $188.0K | · | · | $128.0K | $766.0K | · | $199.0K | $201.0K | $217.0K | |
| Total Liabilities | $81M | $68M | $62M | $77M | $75M | $75M | $80M | $88M | $91M | $148M | $141M | $135M | $148M | $164M | $178M | $187M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $22M | $22M | $22M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Retained Earnings | $-579M | $-547M | $-528M | $-548M | $-527M | $-503M | $-482M | $-465M | $-448M | $-481M | $-490M | $-473M | $-465M | $-453M | $-428M | $-400M | |
| Treasury Stock | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | |
| Stockholders' Equity | $45M | $76M | $92M | $17M | $34M | $49M | $56M | $65M | $75M | $37M | $19M | $29M | $34M | $40M | $60M | $84M | |
| Liabilities + Equity | $126M | $144M | $154M | $94M | $109M | $124M | $136M | $153M | $166M | $185M | $160M | $164M | $182M | $205M | $238M | $272M | |
| Shares Outstanding | 26,433,558 | 25,805,898 | 24,088,425 | 12,082,665 | 11,636,981 | 10,548,852 | 8,202,715 | 7,480,521 | 7,123,370 | 6,916,239 | 4,164,038 | 115,680,008 | 115,070,517 | 112,339,421 | 3,698,674 | 110,934,747 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $253.0K | $299.0K | $345.0K | $350.0K | $378.0K | $395.0K | $454.0K | $715.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $5M | $5M | |
| Operating Cash Flow | $-13M | $-12M | $-11M | $-15M | $-20M | $-19M | $-19M | $-6M | $-15M | $-19M | $-8M | $-23M | $-21M | $-31M | $-22M | $29M | |
| CapEx | $0 | $18.0K | $19.0K | $0 | $2.0K | $64.0K | $97.0K | $39.0K | $28.0K | $86.0K | $-26.0K | $386.0K | $1M | $521.0K | $632.0K | $1M | |
| Investing Cash Flow | $1.0K | $-114.0K | $-325.0K | $17.0K | $-12.0K | $-314.0K | $-97.0K | $-64.0K | $-28.0K | $-26.0K | $42.0K | $8M | $-1M | $-721.0K | $-632.0K | $-1M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $-138.0K | $2M | $445.0K | $0 | $-190.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $445.0K | · | · | |
| Financing Cash Flow | $0 | $745.0K | $78M | $2M | $5M | $11M | $6M | $4M | $702.0K | $40M | $3M | $-34.0K | $2M | $741.0K | $0 | $-180.0K | |
| Net Change in Cash | $-13M | $-11M | $66M | $-14M | $-15M | $-9M | $-13M | $-2M | $-14M | $21M | $-6M | $-16M | $-20M | $-31M | $-22M | $28M | |
| Free Cash Flow | · | $-12M | · | · | · | $-19M | · | · | · | $-19M | · | · | · | $-32M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -83.7% | · | -158976.9% | -121538.9% | -76248.3% | · | -3693.6% | 48.4% | -23.8% | · | -94.2% | -60.6% | -278.6% | · | -311.4% | |
| Net Margin | · | -170.2% | · | -167476.9% | -130666.7% | -70913.8% | · | -2851.6% | 65.6% | 48.8% | · | -61.6% | -60.1% | -285.4% | · | -325.2% | |
| EBITDA Margin | · | -83.7% | · | -158976.9% | -121538.9% | -76248.3% | · | -3693.6% | 48.4% | -23.8% | · | -94.2% | -60.6% | -278.6% | · | -311.4% | |
| ROA | -27.8% | -13.8% | · | -17.6% | -17.1% | -13.3% | · | -10.3% | 18.9% | 4.4% | · | -3.7% | -5.0% | -13.0% | · | -9.6% | |
| ROE | -82.3% | -29.4% | · | -53.4% | -43.2% | -47.5% | · | -35.0% | 60.2% | 22.2% | · | -14.2% | -17.3% | -45.6% | · | -25.8% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.8 | 14.0 | · | 3.4 | 5.2 | 6.6 | · | 9.2 | 4.4 | 4.8 | · | 2.9 | 2.6 | 3.6 | · | 3.7 | |
| Quick Ratio | 12.3 | 13.6 | · | 3.0 | 4.6 | 6.2 | · | 8.5 | 3.8 | 4.1 | · | 2.5 | 2.5 | 3.4 | · | 3.5 | |
| Interest Coverage | · | · | · | · | · | -62.5 | · | -83.1 | 43.1 | -7.3 | · | -21.5 | -21.7 | -46.9 | · | -56.6 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.3 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | 5.4 | · | 0.1 | 0.2 | 0.1 | · | 0.3 | 116.2 | 32.4 | · | 6.2 | 0.8 | 14.9 | · | 12.2 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.71 | $2.95 | · | $1.38 | $2.93 | $4.68 | · | $8.67 | $10.49 | $5.38 | · | $0.25 | $0.30 | $0.36 | · | $0.76 | |
| Revenue / Share | $0.00 | $0.44 | · | $0.00 | $0.00 | $0.00 | · | $0.08 | $7.12 | $3.47 | · | $0.11 | $0.17 | $0.08 | · | $0.07 | |
| Cash Flow / Share | · | $-0.48 | · | · | · | $-2.05 | · | · | · | $-3.75 | · | · | · | $-0.28 | · | · | |
| Cash / Share | $3.26 | $3.85 | · | $3.71 | $5.35 | $7.32 | · | $13.20 | $17.35 | $19.92 | · | $1.06 | $1.20 | $1.41 | · | $1.91 | |
| EPS (TTM) | $-1.23 | $-2.10 | · | $-9.26 | $-9.67 | $-2.87 | · | $0.14 | $0.29 | $-7.51 | · | $-48.94 | $-47.06 | $-44.39 | · | $-1.52 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $45M | $45M | · | $698.0K | $1M | $51M | · | $75M | $88M | $58M | · | $52M | $47M | $31M | · | $21M | |
| Net Income TTM | $-53M | $-44M | · | $-84M | $-78M | $-22M | · | $9M | $17M | $-28M | · | $-74M | $-89M | $-109M | · | $-105M | |
| Market Cap | $208M | $142M | · | $67M | $49M | $50M | · | $67M | $69M | $94M | · | $1.18B | $1.82B | $2.54B | · | $4.33B | |
| P/E | -6.4 | -2.6 | · | -0.6 | -0.4 | -1.7 | · | 64.0 | 33.6 | -1.8 | · | -0.2 | -0.3 | -0.5 | · | -25.7 | |
| P/S | 4.6 | 3.1 | · | 95.6 | 38.8 | 1.0 | · | 0.9 | 0.8 | 1.6 | · | 22.6 | 39.0 | 83.1 | · | 207.6 | |
| P/B | 4.6 | 1.9 | · | 4.0 | 1.4 | 1.0 | · | 1.0 | 0.9 | 2.5 | · | 40.7 | 53.3 | 63.2 | · | 51.3 | |
| P / Tangible Book | 4.7 | 1.9 | · | 4.3 | 1.5 | 1.0 | · | 1.0 | 0.9 | 2.5 | · | 42.1 | 55.9 | 65.7 | · | 52.5 | |
| P / Cash Flow | · | -11.9 | · | · | · | -2.6 | · | · | · | -4.9 | · | · | · | -80.8 | · | · | |
| Earnings Yield | -15.7% | -38.2% | · | -167.8% | -230.2% | -60.2% | · | 1.6% | 3.0% | -55.4% | · | -478.4% | -298.2% | -196.2% | · | -3.9% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $34M | $69M | $49M | $25M | $116M |
| Operating Margin % | -152.2% | -38.1% | -89.8% | -399.9% | -34.1% |
| Net Income | $-46M | $7M | $-61M | $-112M | $-31M |
| Diluted EPS | $-3.56 | $1.04 | $-15.96 | $-38.10 | $-0.52 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 13.3 | 6.3 | 2.7 | 3.3 | 4.5 |
| Quick Ratio | 13.0 | 5.8 | 2.4 | 3.2 | 4.0 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-66M | $-59M | $-86M | $-49M | $-16M |
Institutional owners (13F) 101 filers · $144.1M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
101
Value held
$144.1M
New positions
33
Exited positions
12
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 33 (+10 vs prior Q) | 12 (+2 vs prior Q) | 31 (+7 vs prior Q) | 14 (+1 vs prior Q) | +1.5M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Aberdeen Group plc | $17,529,199 | 2,230,178 | 12.16% | Shares |
| Bleichroeder LP | $15,862,973 | 2,018,190 | 11.00% | Shares |
| Octagon Capital Advisors LP | $10,611,000 | 1,350,000 | 7.36% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $10,579,591 | 1,346,004 | 7.34% | Shares |
| BlackRock, Inc. | $9,218,782 | 1,172,873 | 6.40% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $8,773,654 | 1,116,241 | 6.09% | Shares |
| Lynx1 Capital Management LP | $7,470,663 | 950,466 | 5.18% | Shares |
| Driehaus Capital Management LLC | $7,441,117 | 946,707 | 5.16% | Shares |
| Empery Asset Management, LP | $6,100,091 | 776,093 | 4.23% | Shares |
| Affinity Asset Advisors, LLC | $5,082,087 | 646,576 | 3.53% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $4,882,639 | 620,981 | 3.39% | Shares |
| MACKENZIE FINANCIAL CORP | $3,780,636 | 480,997 | 2.62% | Shares |
| VANGUARD GROUP INC | $3,772,213 | 906,782 | 2.62% | Shares |
| Aquilo Capital Management, LLC | $3,463,731 | 726,149 | 2.40% | Shares |
| STATE STREET CORP | $3,358,775 | 427,325 | 2.33% | Shares |
| ArrowMark Colorado Holdings LLC | $2,154,740 | 274,140 | 1.49% | Shares |
| Corient Private Wealth LP | $1,926,156 | 245,058 | 1.34% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,869,603 | 237,863 | 1.30% | Shares |
| NORTHERN TRUST CORP | $1,494,878 | 190,188 | 1.04% | Shares |
| JPMORGAN CHASE & CO | $1,429,179 | 180,452 | 0.99% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,308,989 | 166,538 | 0.91% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,271,607 | 161,782 | 0.88% | Shares |
| GOLDMAN SACHS GROUP INC | $1,099,048 | 139,828 | 0.76% | Shares |
| Squarepoint Ops LLC | $1,077,653 | 137,106 | 0.75% | Shares |
| MORGAN STANLEY | $1,026,012 | 130,536 | 0.71% | Shares |
| COMMONWEALTH EQUITY SERVICES, LLC | $911,200 | 115,929 | 0.63% | Shares |
| Quarry LP | $769,612 | 97,915 | 0.53% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $679,736 | 86,461 | 0.47% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $615,650 | 78,327 | 0.43% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $539,015 | 68,577 | 0.37% | Shares |
| CITADEL ADVISORS LLC | $538,819 | 68,552 | 0.37% | Shares |
| Jump Financial, LLC | $525,048 | 66,800 | 0.36% | Shares |
| Bank of New York Mellon Corp | $466,780 | 59,387 | 0.32% | Shares |
| UBS Group AG | $461,374 | 58,699 | 0.32% | Shares |
| Trexquant Investment LP | $449,285 | 57,161 | 0.31% | Shares |
| TWO SIGMA ADVISERS, LP | $347,123 | 83,443 | 0.24% | Shares |
| Velan Capital Investment Management LP | $314,400 | 40,000 | 0.22% | Shares |
| BANK OF AMERICA CORP /DE/ | $261,793 | 33,307 | 0.18% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $258,570 | 32,897 | 0.18% | Shares |
| Nuveen, LLC | $253,776 | 32,287 | 0.18% | Shares |
| LPL Financial LLC | $227,987 | 29,006 | 0.16% | Shares |
| ALGERT GLOBAL LLC | $225,818 | 28,730 | 0.16% | Shares |
| RHUMBLINE ADVISERS | $219,004 | 27,864 | 0.15% | Shares |
| Invesco Ltd. | $216,795 | 27,582 | 0.15% | Shares |
| Susquehanna Portfolio Strategies, LLC | $191,855 | 24,409 | 0.13% | Shares |
| DEUTSCHE BANK AG\ | $183,987 | 23,408 | 0.13% | Shares |
| Graham Capital Management, L.P. | $168,267 | 21,408 | 0.12% | Shares |
| Engineers Gate Manager LP | $164,274 | 20,900 | 0.11% | Shares |
| Almanack Investment Partners, LLC. | $160,564 | 20,428 | 0.11% | Shares |
| WELLS FARGO & COMPANY/MN | $158,206 | 20,128 | 0.11% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| venBio Global Strategic Fund, L.P., venBio Global Strategic GP, L.P., venBio Global Strategic GP, Ltd., Robert Adelman, Corey Goodman ×4 filings | July 9, 2020 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 22 insiders · 10 officers · 11 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Michael Amoroso | President and CEO | June 1, 2026 A | 243,392 | 0 | 3 | $-246,183 |
| Fayaz Khazi | CEO of Elo Life Systems | June 7, 2021 A | · | 0 | 0 | $0 |
| John Alexander Kelly | Chief Financial Officer | June 1, 2026 A | 125,883 | 0 | 3 | $-101,056 |
| Abid Ansari | Chief Financial Officer | June 15, 2020 M | 144,401 | 0 | 0 | $0 |
| Dario Scimeca | General Counsel and Secretary | June 1, 2026 A | 56,457 | 0 | 3 | $-58,910 |
| Jefferson J. Smith | Chief Research Officer | June 1, 2026 A | 121,926 | 0 | 2 | $-60,018 |
| Alan List | Chief Medical Officer | May 1, 2024 M | 4,488 | 0 | 0 | $0 |
| Shane Barton | VP & Corporate Controller | June 7, 2023 M | 27,502 | 0 | 0 | $0 |
| Derek Jantz | Chief Scientific Officer | June 7, 2022 M | 4,055,174 | 0 | 0 | $0 |
| Christopher Heery | Chief Medical Officer | June 8, 2020 A | 2,485 | 0 | 0 | $0 |
| Stanley Frankel | Director | Sept. 28, 2026 P | 41,478 | 2 | 0 | $18,690 |
| Melinda Brown | Director | Sept. 25, 2026 P | 45,481 | 2 | 0 | $13,980 |
| Geno J Germano | Director | Sept. 25, 2026 P | 47,492 | 2 | 0 | $30,545 |
| Shari Lisa Pire | Director | June 3, 2026 A | 35,028 | 0 | 0 | $0 |
| Kevin Buehler | Director | June 3, 2026 A | 49,137 | 0 | 0 | $0 |
| Samuel C. Wadsworth | Director | June 4, 2024 A | 4,202 | 0 | 0 | $0 |
| Raymond F Schinazi | Director | May 10, 2022 A | 93,048 | 0 | 0 | $0 |
| Shalini Sharp | Director | May 10, 2021 A | · | 0 | 0 | $0 |
| Tony Dung Ling Yao | Director | April 3, 2019 P | 158,003 | 0 | 0 | $0 |
| David S. Thomson | · | June 23, 2021 M | 111,513 | 0 | 0 | $0 |
| Matthew R. Kane | · | Aug. 21, 2020 A | 2,013,597 | 0 | 0 | $0 |
| FMR LLC | · | April 1, 2019 C | 3,738,248 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 14 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.42% | 15,689 SH | Oct. 1, 2026 | Daily |
| IWC · iShares Trust | 0.04% | 81,843 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 138,702 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 20,860 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 11,471 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.01% | 551,584 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.00% | 20,808 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 2,947 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 2,884 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 5,826 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 312,368 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 778,139 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,220 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 219,085 SH | Sept. 11, 2026 | Daily |
DTIL Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 11 analysts
BUY
Median target
$20.00
+217.0%
5 45.5%
Strong Buy
5 45.5%
Buy
1 9.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
5 analysts · 2026-09-20Mean target $29.40 +365.9%
← Below all targets
Current price $6.31
Low$18.00
Mean$29.40
High$60.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | · |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | · |
| NKTX | $131M | -1.3 | · | · | -31.1% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | · |
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | · |
| CMPX | $958M | · | · | · | -45.9% | · |
| AVXL | · | -16.5 | -36.1% | -991.4% | · | · |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | · |
| TARA | $286M | -4.0 | · | · | -33.7% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 6, 2026